Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
1. To compare prophylactic effect of ondansetron versus ramosetron on radiotherapy induced
nausea and vomiting in the treatment of gastrointestinal cancer.
2. To verify an improvement of 20% in complete response rate in term of radiotherapy
induced nausea and vomiting (from 60% with ondansetron to 80% with ramosetron).